What is FDA Form 483 and how long do I have to respond?

Form 483 is issued at the end of an FDA inspection listing inspectional observations. You typically have 15 business days to submit a written response to the issuing investigator, though FDA generally expects a response within 15 calendar days.

What should a 483 response include?

A good 483 response addresses each observation individually with: (1) acknowledgement of the finding, (2) root cause analysis, (3) immediate corrective actions taken, (4) systemic corrections across your QMS, and (5) timelines for completion.

What happens if I don't respond to a Form 483?

Failing to respond promptly and adequately can lead to a Warning Letter, import alert, consent decree, or other enforcement action. A timely, substantive response that demonstrates understanding and corrective action significantly reduces this risk.

Book an FDA Form 483 Response Pack

Book expert FDA Form 483 response support online. Compare vetted regulatory consultants who draft formal 483 responses with CAPA plans. Instant per-observation pricing.

✓ 3 active providers available right now · USD 1,127 – 1,393

Why this page is different

Instant pricing: See a price estimate immediately (no back-and-forth RFQ needed for these services).
Compare before booking: Review inclusions, exclusions, turnaround, and communication channels.
Charged only when accepted: You are charged only after a provider accepts your order and scope.
Live availability: 3 active providers available right now for this service.

What you can compare here

Total price: See live price ranges and instant pricing rules where available.
Coverage & scope: Markets served, what is included, and what is explicitly excluded.
SLA & responsiveness: Acceptance SLAs and typical turnaround windows.
Add-ons: Optional extras you can book next (shown as add-on chips).
Onboarding time: How quickly providers can start and what you need to supply.

Compare providers (instant pricing + book)

Provider	Estimated base price	Accept SLA	Turnaround	Start
Alpha Regulatory Partners	USD 1,225	24h	3–7 days	Within 2 business days
Beta Compliance Group	USD 1,393	24h	3–7 days	Within 2 business days
Gamma RegTech Solutions	USD 1,127	24h	3–7 days	Within 2 business days

Estimates are derived from each provider’s published pricing rules (and may vary by your inputs).

What affects pricing

These are the inputs providers use to price your order. Enter them once, then compare providers and book instantly.

observationsCount (Required)
min 1
urgency (Required)
standard|urgent
desiredOutputs (Required)
min 1
buyerNotes (Optional)

⚠️

Input

Form 483 observations

📄

Output

Written response + CAPA plan

⏱️

Turnaround

5–15 business days

💰

Pricing

Per observation / per pack

How it works

1

Share your Form 483 observations

Upload your FDA Form 483 with the inspector's observations and any background QMS documentation relevant to each finding.
2

Compare 483 response specialists

View per-observation or per-pack fees from consultants experienced in drafting regulatory-grade FDA responses.
3

Receive your draft response and CAPA plan

Your consultant drafts a formal written response to FDA with root cause analysis, corrective actions, and preventive measures for each observation.

What is FDA Form 483?

Form 483 is a document issued by FDA investigators at the conclusion of an inspection of a regulated establishment — a medical device manufacturer, drug facility, food processor, or laboratory. It lists "inspectional observations" — specific conditions the investigator observed that, in their judgment, may represent violations of the FD&C Act or applicable regulations. A Form 483 is not a final determination of violation; it is an opportunity for the establishment to respond and correct issues before FDA takes formal enforcement action. The observations are organized by regulation (e.g., 21 CFR 820.30 for design controls, 820.100 for CAPA) and should be read carefully against the applicable regulatory text.

The anatomy of a strong Form 483 response

FDA expects a written response within 15 business days. A strong response addresses each observation individually and includes: (1) a concise acknowledgement of the observation without admission of regulatory violation; (2) the root cause investigation — specifically, the systems failure that allowed the condition to occur, not just the immediate cause; (3) immediate corrective actions already taken (with evidence); (4) systemic corrections across your entire QMS that prevent recurrence; (5) how you verified that the corrective action was effective; and (6) realistic target completion dates for any open actions. Observations that receive vague, incomplete, or defensive responses are more likely to result in Warning Letters.

What happens if FDA is unsatisfied with your 483 response?

If FDA finds your 483 response inadequate, they can escalate to a Warning Letter — a public, formal notice of alleged violation. Warning Letters are posted on FDA's website and can trigger customer concern, distributor contract clauses, and investor scrutiny. Continued non-compliance can lead to consent decrees, import alerts, product seizure, or injunctive action. A well-drafted 483 response that demonstrates genuine understanding and effective corrective action is the most important thing you can do to prevent escalation. Responding with a formal corrective action plan — rather than just a letter — signals organizational commitment to compliance.

When should you involve a regulatory consultant?

You should involve a consultant if: (1) you have multiple or complex observations spanning several QMS subsystems; (2) any observation relates to design validation, CAPA effectiveness, or post-market surveillance — areas FDA scrutinizes closely for systemic weakness; (3) you have a prior history of 483 observations or Warning Letters on similar issues; or (4) your internal regulatory team is stretched. A consultant experienced with FDA inspections can help you frame observations accurately, identify root causes you may have missed, and structure the written response to FDA's expected format.

Frequently asked questions

What is FDA Form 483 and how long do I have to respond?: Form 483 is issued at the end of an FDA inspection listing inspectional observations. You typically have 15 business days to submit a written response to the issuing investigator, though FDA generally expects a response within 15 calendar days.
What should a 483 response include?: A good 483 response addresses each observation individually with: (1) acknowledgement of the finding, (2) root cause analysis, (3) immediate corrective actions taken, (4) systemic corrections across your QMS, and (5) timelines for completion.
What happens if I don't respond to a Form 483?: Failing to respond promptly and adequately can lead to a Warning Letter, import alert, consent decree, or other enforcement action. A timely, substantive response that demonstrates understanding and corrective action significantly reduces this risk.

How Cruxi Bridge vets providers

✓ Every provider submits regulatory expertise evidence and jurisdictional coverage claims
✓ Providers that go live agree to the Cruxi Bridge Provider Terms including service delivery and accuracy obligations
✓ Payment is held by Cruxi and only released to the provider after service delivery milestones
✓ Buyers can raise a dispute within 30 days — Cruxi reviews and mediates per the platform terms

Prices and provider availability are live and may change. Charged only when a provider accepts your order. ← All services